Navigation Links
AMP comments at FDA meeting on array-based tests
Date:6/30/2010

Bethesda, MD (June 30, 2010): Today, the Association for Molecular Pathology (AMP) presented comments at the US Food & Drug Administration's public meeting on array-based cytogenetic tests. The FDA convened the meeting to seek answers to more than a dozen questions they had on how to evaluate the performance, interpret results and report findings of array-based cytogenetic tests for copy number variation (CNV).

AMP believes array-based cytogenetic tests provide much higher resolution than traditional karyotyping, with expansive capabilities to diagnose and identify causes of genetic syndromes due to chromosome abnormalities. The standard of care in molecular and cytogenetic laboratories as well as genetics clinics is shifting from traditional karyotyping to array-based cytogenomic analysis. "This new technology has provided diagnoses that would have otherwise not been possible with older methods," explained Dr. Mark Sobel, AMP Executive Director.

Professional societies, such as AMP, are currently working to develop professional practice guidelines to address many of the questions raised by the FDA that focus on interpreting and reporting results of array-based cytogenetic tests. AMP believes that the interpretation of these tests falls within the scope of professional practice and that while the FDA should evaluate the technology platform for analytical validity, the FDA does not need to review each possible CNV result. "It is important to remember that all testing is performed in the context of the phenotype of the patient, and interpretation of laboratory data is a collaboration between the clinical scientist and the treating physician," said Dr. Sobel. AMP encourages the FDA to partner with professional associations to collaborate on the best manner to standardize the use and reporting of array-based tests.

AMP believes that to advance the use of array-based cytogenetic tests, the molecular cytogenetic field needs to collect data on both the laboratory results and clinical information. Dr. Sobel added, "Such a database will enable the community to continually assess the validity of results and accelerate the understanding of the results." AMP encourages the government to fund clinical research to further explore the associations between array findings and health information.


'/>"/>

Contact: Mary Steele Williams
mwilliams@amp.org
301-634-7921
Association for Molecular Pathology
Source:Eurekalert

Related biology news :

1. AVAC comments on NIAID decision not to move forward with PAVE 100 Trial
2. Director of Berman Institute comments on FDA Approval of first human embryonic stem cell trial
3. AMP submits comments on SACGHS report
4. Society for General Microbiology 161st Meeting, University of Edinburgh
5. Planetary geoscience, paleontology, and more at GSA Annual Meeting in Denver next month
6. Colony collapse disorder symposium added to ESA Annual Meeting
7. Meeting real-world climate information needs of business, government
8. Food and environmental sustainability focus of ASA-CSSA-SSSA Annual Meetings
9. NAS Biodiversity and Extinction Meeting Dec. 7-8
10. HGS announces positive Phase 2 LymphoStat-B at ACR meeting
11. New studies on schizophrenia, depression, trauma and autism highlight annual meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/11/2017)... Apr. 11, 2017 Research and Markets has ... report to their offering. ... The global eye tracking market to grow at a CAGR of ... Eye Tracking Market 2017-2021, has been prepared based on an in-depth ... market landscape and its growth prospects over the coming years. The ...
(Date:4/5/2017)... Today HYPR Corp. , leading innovator ... of the HYPR platform is officially FIDO® Certified ... architecture that empowers biometric authentication across Fortune 500 enterprises ... over 15 million users across the financial services industry, ... product suites and physical access represent a growing portion ...
(Date:3/30/2017)... 2017 The research team of The Hong ... fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery and ... speed and accuracy for use in identification, crime investigation, immigration control, ... ... A research team led ...
Breaking Biology News(10 mins):
(Date:4/20/2017)... ... 2017 , ... Energetiq Technology , a world leader ... Executive Officer (CEO) Debbie Gustafson has been appointed to the SEMI North America ... the electronics manufacturing supply chain. The mission of the SEMI NAAB is to ...
(Date:4/20/2017)... Israel , April 20, 2017  BrainStorm ... stem cell technologies for neurodegenerative diseases, announced today that ... Alliance for Regenerative Medicine,s (ARM) 5 th Annual Cell ... at 09:40 EDT in Boston . ... Chief Medical Officer & Chief Operating Officer, will participate in ...
(Date:4/19/2017)... Indiana (PRWEB) , ... April 18, 2017 , ... Alisa ... 2017 Distinguished Alumni Awards from the Purdue College of Pharmacy in Lafayette, Indiana. ... Purdue Pharmacy Program for achievements in their careers and other scientific endeavors. , ...
(Date:4/19/2017)... ... 19, 2017 , ... WHO: Peggy Lillis Foundation, the preeminent ... advocacy. Founded in 2010 in memory of a single-parent mom and kindergarten teacher ... the most-consulted source for patient-focused information on C. diff infections in the nation. ...
Breaking Biology Technology: